Telemedicine Referral for Childhood Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new telemedicine approach to help children in rural Alaska with hearing loss receive necessary follow-up care. The researchers aim to determine if using telemedicine directly in schools can improve follow-up rates compared to the usual method of sending a letter to parents. The trial will occur in three regions and involve students from kindergarten to 12th grade. It is ideal for families with children in these areas who have experienced hearing issues but have not always received the follow-up care they need. As an unphased trial, this study offers families the chance to contribute to innovative solutions that could enhance healthcare access for children in rural communities.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on telemedicine for hearing loss, not medication.
What prior data suggests that this telemedicine intervention is safe for childhood hearing loss referrals?
Research shows that telemedicine, including the STAR model, is generally safe and easy to use. Studies on telemedicine in schools have found it improves follow-up care without causing significant problems. The technology, already common in healthcare, is considered safe for patients.
This trial will use mobile health (mHealth) tools for hearing tests in schools. Current evidence suggests these tools are easy to use and safe for children. Previous studies have not found any serious side effects from these technologies.
In summary, past research indicates that this telemedicine approach is well-tolerated, with no major safety concerns. It offers a promising way to improve access to necessary follow-up care in rural areas.12345Why are researchers excited about this trial?
Researchers are excited about the Telemedicine Referral for Childhood Hearing Loss trial because it could revolutionize how kids access care for hearing issues. Unlike traditional referral methods that often require multiple in-person visits, the study tests a telemedicine approach. This approach allows for quicker and more convenient access to specialists, especially for families living in remote areas. By leveraging technology, this method aims to streamline the referral process, reduce wait times, and improve overall access to essential hearing health services for children.
What evidence suggests that the STAR intervention is effective for reducing loss to follow-up in childhood hearing loss?
Research has shown that telemedicine can significantly reduce the number of children in rural areas who miss follow-up care for hearing loss. This trial will compare two approaches: the Specialty Telemedicine Access for Referrals (STAR) and Standard Referral. Studies have found that mobile health screenings combined with telemedicine referrals, as in the STAR arm of this trial, increase follow-up rates after initial school hearing tests. In rural Alaska, past trials demonstrated that using telemedicine in schools reduced the number of children missing necessary follow-up care. This method addresses the shortage of specialists and ensures more children receive needed care after being flagged for possible hearing issues. By facilitating virtual visits with specialists, telemedicine can help prevent long-term hearing problems in children.23567
Who Is on the Research Team?
Matthew Hirschfeld, MD,PhD
Principal Investigator
Vice President-Specialty Services, Southcentral Foundation, Alaska Native Medical Center
Susan Emmett, MD, MPH
Principal Investigator
University of Arkansas Medical Sciences
Are You a Good Fit for This Trial?
This trial is for children in grades K-12 attending participating schools in rural Alaska regions. It aims to address high rates of childhood hearing loss, which is often preventable and related to infections.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enhanced Screening
Implementation of enhanced mobile health (mHealth) hearing screening in all participating schools
STAR Intervention
Telemedicine referral to specialty care moved from clinic to school, evaluated in a stepped-wedge manner
Follow-up
Participants are monitored for follow-up after hearing screening and intervention
What Are the Treatments Tested in This Trial?
Interventions
- School Screening and Telemedicine Specialty Referral
- Specialty Telemedicine Access for Referrals (STAR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas
Lead Sponsor
Southcentral Foundation
Collaborator
Duke University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator